ANGISCEIN

Serial Number 75454261
Registration 2402460
710

Registration Progress

Application Filed
Mar 20, 1998
Under Examination
Apr 13, 1999
Approved for Publication
Dec 18, 1998
Published for Opposition
Jan 19, 1999
Registered
Nov 7, 2000

Basic Information

Serial Number
75454261
Registration Number
2402460
Filing Date
March 20, 1998
Registration Date
November 7, 2000
Published for Opposition
January 19, 1999
Cancellation Date
August 11, 2007
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Aug 11, 2007

Rights Holder

NOVARTIS AG

03
Address
4002 Basle
CH

Ownership History

NOVARTIS AG

Original Applicant
03
4002 Basle CH

NOVARTIS AG

Owner at Publication
03
4002 Basle CH

NOVARTIS AG

Original Registrant
03
4002 Basle CH

Legal Representation

Attorney
BARRY A SOLOMON

USPTO Deadlines

Next Renewal Deadline
1949 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2000-11-07)
Due Date
November 07, 2030
Grace Period Ends
May 07, 2031

Application History

16 events
Date Code Type Description
Aug 11, 2007 C8.. O CANCELLED SEC. 8 (6-YR)
Aug 8, 2006 CFIT O CASE FILE IN TICRS
Dec 19, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2004 MAIL I PAPER RECEIVED
Nov 7, 2000 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 5, 2000 DOCK D ASSIGNED TO EXAMINER
Jul 5, 2000 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 29, 2000 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Oct 27, 1999 IUAF S USE AMENDMENT FILED
Sep 30, 1999 EXT1 S SOU EXTENSION 1 FILED
Sep 30, 1999 EX1G S SOU EXTENSION 1 GRANTED
Apr 13, 1999 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 19, 1999 PUBO A PUBLISHED FOR OPPOSITION
Dec 18, 1998 NPUB O NOTICE OF PUBLICATION
Oct 21, 1998 DOCK D ASSIGNED TO EXAMINER
Oct 21, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER